Medicine News

BHR Pharma Enrolls First Patient In Phase 3 SyNAPSe Traumatic Brain Injury Trial
Tue, 27 July 2010
BHR Pharma, LLC (BHR) announced that the first patient has been enrolled in its SyNAPSe study , a global, Phase 3, pivotal trial to evaluate the safety and effectiveness of its intravenous progesterone infusion product (BHR-100) as a neuroprotective agent for treating severe (Glasgow Coma Scale scores of 4-8) traumatic brain ...
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data From Phase 2b Study
Tue, 27 July 2010
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma...
Tibotec Pharmaceuticals Submits New Drug Application For Investigational Once-Daily HIV ...
Tue, 27 July 2010
Tibotec Pharmaceuticals announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infect ...
Two New Tuberculosis (TB) Drugs Show Significant Synergy In Vitro
Tue, 27 July 2010
Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec ...
Non-Human Sugar In Biotech Drugs Causes Inflamation
Mon, 26 July 2010
Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response in some people, likely worsening conditions in which chronic inflammation is a major issue...
Ohio Sets Up High Risk Pool; Four Drug Companies Come Under Scrutiny For Payments To Pit ...
Mon, 26 July 2010
The Associated Press/Bloomberg BusinessWeek: Ohioans with pre-existing health conditions, such as cancer or diabetes, can apply for coverage under a new high-risk insurance pool beginning Aug. 1. Qualifications include evidence of a pre-existing condition, proof of Ohio residency and U.S...
Panel Turns Down FDA Proposal To Control Prescription Narcotic Painkillers
Mon, 26 July 2010
An FDA (Food and Drug Administration), USA Advisory Committee voted 25 to 10 against a proposal to reduce the abuse and misuse of long-acting narcotic painkillers, such as OxyContin or Vicodin. Although the Advisory Committee's recommendations are not binding the FDA usually follows them when making a regulatory decision...
GE Healthcare Inaugurates Its First Factory In Brazil
Sat, 24 July 2010
GE Healthcare, a unit of GE (NYSE: GE), announced the opening of its first factory in Brazil, as well as South America, in the town of Contagem (MG)...
Federal Government Seizes Cyanide Antidote Kits From California Company
Fri, 23 July 2010
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized 39,000 worth of products labeled as cyanide antidote kits from Keystone Pharmaceuticals in Laguna Hills, California. The seizure warrant was issued by the U.S. District Court for the Central District of California...
News Outlets Report On Medical Intellectual Property Developments, Drug Access Issues
Fri, 23 July 2010
Inter Press Service reports on a recent symposium on access to medicine, jointly hosted by the WHO, the World Trade Organization (WTO) and the World Intellectual Property Organisation (WIPO)...

News

This section contains news related to the medicine industry.

Publishers of medicine related news can register for free on our website and add their medicine news to this website.

Our websites

Chemicals 1.com

GMP 1.com

Laboratory Supplies 1.com

Medical Products 1.com

Pharmaceuticals 1.com

Veterinary Products 1.com

More 1.com websites...

- About us
- About Medicines 1.com
- Email us
- Terms of use
- Using Medicines 1.com
- Register (free) / Join now
- Memberships
- How to buy/sell
- FAQ / Help

Medicine News - Medicines 1.com

Members in

Algeria
Angola
Benin
Botswana
Burundi
Cameroon
Cote d Ivoire
Djibouti
Ethiopia
Ghana
Guinea
Kenya
Liberia
Libyan Arab Jamahiriya
Malawi
Maldives
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Senegal
Sierra Leone
Somalia
South Africa
Sudan
Tanzania, United Republic of
Togo
Tunisia
Uganda
Zaire
Zambia
Zimbabwe
Afghanistan
Bangladesh
Bermuda
Brunei Darussalam
Cambodia
China
Hong Kong
India
Indonesia
Japan
Kazakhstan
Kyrgyzstan
Malaysia
Mongolia
Myanmar
Nepal
Pakistan
Papua New Guinea
Philippines
Singapore
South Korea
Sri Lanka
Taiwan
Tajikistan
Thailand
Viet Nam
Albania
Armenia
Austria
Azerbaijan
Belarus
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Macedonia
Malta
Moldova,Republic of
Netherlands (Holland)
Norway
Poland
Portugal
Republic of Serbia
Romania
Russian Federation
San Marino
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
Uzbekistan
Vatican City State (Holy See)
Yugoslavia
Bahrain
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Oman
Qatar
Saudi Arabia
Swaziland
Syrian Arab Republic
United Arab Emirates
Yemen
Antigua and Barbuda
Aruba
Bahamas
Barbados
Belize
Canada
Costa Rica
Cuba
Dominican Republic
El Salvador
Guatemala
Haiti
Honduras
Jamaica
Mexico
Netherlands Antilles
Nicaragua
Panama
Puerto Rico
Trinidad and Tobago
United States
Australia
Fiji
New Zealand
Saint Vincent and the Grenadines
Argentina
Bolivia
Brazil
Chile
Colombia
Ecuador
Paraguay
Peru
Suriname
Uruguay
Venezuela
American Samoa
Equatorial Guinea
Lesotho
Grenada

Medicine News

News

Advertisements